Ursodeoxycholic Acid Ameliorates Pain Severity and Cartilage Degeneration in Monosodium Iodoacetate-Induced Osteoarthritis in Rats |
Moon, Su-Jin
(Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Jeong, Jeong-Hee (The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea) Jhun, Joo Yeon (The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea) Yang, Eun Ji (The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea) Min, Jun-Ki (Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Choi, Jong Young (Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Cho, Mi-La (The Rheumatism Research Center, Catholic Research Institute of Medical Science, The Catholic University of Korea) |
1 | Poupon, R. E., B. Balkau, E. Eschwege, and R. Poupon. 1991. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N. Engl. J. Med. 324: 1548-1554. DOI ScienceOn |
2 | Corpechot, C., F. Carrat, A. Bahr, Y. Chretien, R. E. Poupon, and R. Poupon. 2005. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128: 297-303. DOI ScienceOn |
3 | Okada, K., J. Shoda, K. Taguchi, J. M. Maher, K. Ishizaki, Y. Inoue, M. Ohtsuki, N. Goto, K. Takeda, H. Utsunomiya, K. Oda, E. Warabi, T. Ishii, K. Osaka, I. Hyodo, and M. Yamamoto. 2008. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G735-747. DOI ScienceOn |
4 | Kim, J., Y. N. Cha, and Y. J. Surh. 2010. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat. Res. 690: 12-23. DOI ScienceOn |
5 | Sanghi, D., S. Avasthi, A. Mishra, A. Singh, S. Agarwal, and R. N. Srivastava. 2011. Is radiology a determinant of pain, stiffness, and functional disability in knee osteoarthritis? A cross-sectional study. J. Orthop. Sci. 16: 719-725. DOI |
6 | Cotofana, S., B. T. Wyman, O. Benichou, D. Dreher, M. Nevitt, J. Gardiner, W. Wirth, W. Hitzl, C. K. Kwoh, F. Eckstein, and R. B. Frobell. 2013. Relationship between knee pain and the presence, location, size and phenotype of femorotibial denuded areas of subchondral bone as visualized by MRI. Osteoarthritis Cartilage 21: 1214-1222. DOI ScienceOn |
7 | Dean, D. D., W. Azzo, J. Martel-Pelletier, J. P. Pelletier, and J. F. Woessner, Jr. 1987. Levels of metalloproteases and tissue inhibitor of metalloproteases in human osteoarthritic cartilage. J. Rheumatol. 14 Spec No: 43-44. |
8 | Tanaka, S., C. Hamanishi, H. Kikuchi, and K. Fukuda. 1998. Factors related to degradation of articular cartilage in osteoarthritis: a review. Semin. Arthritis Rheum. 27: 392-399. DOI ScienceOn |
9 | Durigova, M., H. Nagase, J. S. Mort, and P. J. Roughley. 2011. MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein. Matrix Biol. 30: 145-153. DOI ScienceOn |
10 | Song, R. H., M. D. Tortorella, A. M. Malfait, J. T. Alston, Z. Yang, E. C. Arner, and D. W. Griggs. 2007. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 56: 575-585 DOI ScienceOn |
11 | Carlo, M. D. Jr. and R. F. Loeser. 2003. Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis Rheum. 48: 3419-3430. DOI ScienceOn |
12 | Sharma, A. R., S. Jagga, S. S. Lee, and J. S. Nam. 2013. Interplay between Cartilage and Subchondral Bone Contributing to Pathogenesis of Osteoarthritis. Int. J. Mol. Sci. 14: 19805-19830. DOI ScienceOn |
13 | Ljubuncic, P., B. Fuhrman, J. Oiknine, M. Aviram, and A. Bomzon. 1996. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut 39: 475-478. DOI ScienceOn |
14 | Lukivskaya, O., L. Zavodnik, M. Knas, and V. Buko. 2006. Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis. Adv. Med. Sci. 51: 54-59. |
15 | Kuettner, K. E., B. U. Pauli, G. Gall, V. A. Memoli, and R. K. Schenk. 1982. Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics, and morphology. J. Cell Biol. 93: 743-750. DOI |
16 | Guzman, R. E., M. G. Evans, S. Bove, B. Morenko, and K. Kilgore. 2003. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol. Pathol. 31: 619-624. DOI |
17 | Kapoor, M., J. Martel-Pelletier, D. Lajeunesse, J. P. Pelletier, and H. Fahmi. 2011. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7: 33-42. DOI ScienceOn |
18 | Kobayashi, K., R. Imaizumi, H. Sumichika, H. Tanaka, M. Goda, A. Fukunari, and H. Komatsu. 2003. Sodium iodoacetate- induced experimental osteoarthritis and associated pain model in rats. J. Vet. Med. Sci. 65: 1195-1199. DOI ScienceOn |
19 | Chevalier, X., B. Giraudeau, T. Conrozier, J. Marliere, P. Kiefer, and P. Goupille. 2005. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J. Rheumatol. 32: 1317-1323. |
20 | Scott, J. L., C. Gabrielides, R. K. Davidson, T. E. Swingler, I. M. Clark, G. A. Wallis, R. P. Boot-Handford, T. B. Kirkwood, R. W. Taylor, and D. A. Young. 2010. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann. Rheum. Dis. 69: 1502-1510. DOI ScienceOn |
21 | Pelletier, J. P., D. V. Jovanovic, V. Lascau-Coman, J. C. Fernandes, P. T. Manning, J. R. Connor, M. G. Currie, and J. Martel-Pelletier. 2000. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo : possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum. 43: 1290-1299. DOI ScienceOn |
22 | Tiku, M. L., R. Shah, and G. T. Allison. 2000. Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis. J. Biol. Chem. 275: 20069-20076. DOI ScienceOn |
23 | Mendes, A. F., M. M. Caramona, A. P. Carvalho, and M. C. Lopes. 2003. Hydrogen peroxide mediates interleukin-1betainduced AP-1 activation in articular chondrocytes: implications for the regulation of iNOS expression. Cell Biol. Toxicol. 19: 203-214. DOI ScienceOn |
24 | Tiku, M. L., G. T. Allison, K. Naik, and S. K. Karry. 2003. Malondialdehyde oxidation of cartilage collagen by chondrocytes. Osteoarthritis Cartilage 11: 159-166. DOI ScienceOn |
25 | Poupon, R. E., K. D. Lindor, K. Cauch-Dudek, E. R. Dickson, R. Poupon, and E. J. Heathcote. 1997. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113: 884-890. DOI ScienceOn |
26 | Poupon, R. 2012. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action. Clin. Res. Hepatol. Gastroenterol. 36 Suppl 1: S3-12. DOI ScienceOn |
27 | Lapenna, D., G. Ciofani, D. Festi, M. Neri, S. D. Pierdomenico, M. A. Giamberardino, and F. Cuccurullo. 2002. Antioxidant properties of ursodeoxycholic acid. Biochem. Pharmacol. 64: 1661-1667. DOI ScienceOn |
28 | Felson, D. T. 2006. Clinical practice. Osteoarthritis of the knee. N. Engl. J. Med. 354: 841-848. DOI ScienceOn |
29 | Guerne, P. A., D. A. Carson, and M. Lotz. 1990. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J. Immunol. 144: 499-505. |
30 | Chadjichristos, C., C. Ghayor, M. Kypriotou, G. Martin, E. Renard, L. Ala-Kokko, G. Suske, B. de Crombrugghe, J. P. Pujol, and P. Galera. 2003. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes. J. Biol. Chem. 278: 39762-39772. DOI ScienceOn |
31 | Remans, P. H., C. A. Wijbrandts, M. E. Sanders, R. E. Toes, F. C. Breedveld, P. P. Tak, J. M. van Laar, and K. A. Reedquist. 2006. CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells. Arthritis Rheum. 54: 3135- 3143. DOI ScienceOn |
32 | Najim, R. A., K. E. Sharquie, and A. R. Abu-Raghif. 2007. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters. J. Dermatol. 34: 308-314 DOI ScienceOn |
33 | Huebner, J. L., I. G. Otterness, E. M. Freund, B. Caterson, and V. B. Kraus. 1998. Collagenase 1 and collagenase 3 expression in a guinea pig model of osteoarthritis. Arthritis Rheum. 41: 877-890. DOI |
![]() |